1. Fernandes MGO, Sousa C, Pereira Reis J, Cruz-Martins N, Souto Moura C, Guimarães S, Justino A, Pina MJ, Magalhães A, Queiroga H, Marques JA, Machado JC, Costa JL, Hespanhol V

Liquid Biopsy for Disease Monitoring in Non-Small Cell Lung Cancer: The Link between Biology and the Clinic. Cells 10: ., 2021. [Article] 

 doi: 10.3390/cells10081912 PMID: 34440680.

 

2. Fernandes MGO, Cruz-Martins N, Machado JC, Costa JL, Hespanhol V

The value of cell-free circulating tumour DNA profiling in advanced non-small cell lung cancer (NSCLC) management. Cancer cell international 21: 675, 2021. [Review] 

 doi: 10.1186/s12935-021-02382-0 PMID: 34915883.

 

3. Fernandes MGO, Sousa C, Jacob M, Almeida L, Santos V, Araújo D, Novais Bastos H, Magalhães A, Cirnes L, Moura CS, Queiroga H, Cruz-Martins N, Hespanhol V

Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer. Frontiers in oncology 11: 602924, 2021. [Article] 

 doi: 10.3389/fonc.2021.602924 PMID: 34026599.

 

4. Fernandes MGO, Cruz-Martins N, Souto Moura C, Guimarães S, Pereira Reis J, Justino A, Pina MJ, Magalhães A, Queiroga H, Machado JC, Hespanhol V, Costa JL

Clinical Application of Next-Generation Sequencing of Plasma Cell-Free DNA for Genotyping Untreated Advanced Non-Small Cell Lung Cancer. Cancers 13: ., 2021. [Article] 

 doi: 10.3390/cancers13112707 PMID: 34070940.

 

1. Coelho DB, Santos V, Araújo D, Bastos HN, Magalhães A, Hespanhol V, Queiroga H, Cruz-Martins N, Fernandes MGO

Management of Coronavirus Disease 2019 Patients With Lung Cancer: Experience From a Thoracic Oncology Center. Frontiers in molecular biosciences 8: 639676, 2021. [Article] 

 doi: 10.3389/fmolb.2021.639676 PMID: 34368223.